An interventional study of Negative Control Treatment Slurry (Fluoride-Free) and Active Comparator Fluoride Treatment (0.454% SnF) in Dental Caries, sponsored by Church & Dwight Company, Inc.. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-19.
Sponsored by Church & Dwight Company, Inc. · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 193 studies in Dental Caries with a site in United States — 16 open to participants now, 19 under way, 3 of them phase 3. Dental Caries · United States.
Among the 193 studies in Dental Caries with a site in United States, this one is the 125th largest by enrollment of the 168 interventional ones that give a count, is one of 10 that started in 2024, is one of 110 with no phase, and was the 187th registered.
1,174 studies on the registry are indexed under Dental Caries; 209 are open to participants now.
Browse Dental Caries studies →16 of the 193 studies in Dental Caries with a site in United States are open now. Recruiting first, the newest first:
University of Michigan · Sites in United States
Ages 8–12
University of Michigan · Sites in United States
Ages 18–99
A.T. Still University of Health Sciences · Sites in United States
Ages 6–10
University of Pennsylvania · Sites in United States
Ages 5–13 · Healthy volunteers
University of Massachusetts, Worcester · Sites in United States
Ages 12 mo–45 yrs · Healthy volunteers
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 86 Dental Caries studies recruiting now, 18 (21%) set no upper age limit and 66 (77%) stop at 75 or younger; 60 take children under 18; 53 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
193 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 13 · Phase 2 19 · Phase 3 23 · Phase 4 4
First in 1996; this study’s year is marked. 10 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 31 is below the median of 60 across 967 interventional studies indexed under Dental Caries.
Median enrollment 60 across the 168 interventional studies, 264 across the 25 observational. Of the 166 that completed or were terminated, 68 (41%) have results posted.
This tab as a report to print or save as PDF → With an account.
44 of 193 have an industry lead sponsor. The 10 most frequent:
Church & Dwight Company, Inc. is the lead sponsor of 33 studies on the registry; none are open to participants now.
Church & Dwight Company, Inc. has 3 studies filed under Dental Caries — fewer than ten, so there is no comparison to draw.
6 of the studies in Dental Caries with a site in United States that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07124533Phase 3Loma Linda UniversityEffectiveness of Toothpaste Tablets on Plaque, Gingival Health and Caries Experiences | 2026-12 |
| NCT06588725Vanderbilt University Medical CenterBrief Interventions to Improve Behavior Outcomes and Prevent Cavities | 2027-01 |
| NCT05756413University of IowaBirth to Three - Cavity Free | 2027-03-31 |
| NCT07648212University of MichiganArtificial Intelligence (AI) for Proximal Caries Detection and Its Impact on Treatment Threshold | 2027-05 |
| NCT06714929Virginia Commonwealth UniversityAdvancing Water Security: A Community Participatory School-Based Hydration Intervention | 2027-05-31 |
Add all 6 to your calendar (.ics) → With an account.
Among the 193 studies in Dental Caries with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The primary objective of this crossover in-situ study is to determine the fluoride bioavailability and enamel remineralization potential of an experimental, placebo, and a positive control reference toothpaste.
Each 9-day test period was preceded by a washout period of at least four days during which subjects used a fluoride-free toothpaste. The washout phase ensured removal of residual fluoride exposure prior to beginning the next assigned dentifrice treatment. Subjects remained in good oral health and compliance was verified at the start of each test period.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
be willing to postpone all elective dental procedures, at the discretion of the Investigator/Designee, until the study has been completed.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A planned gap after a treatment, so that its effects can lessen before the study treatment or a study assessment. Ask the study team and the doctor who prescribed it before changing any medicine.
A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.
Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Washout period
A planned gap after a treatment, so that its effects can lessen before the study treatment or a study assessment. Ask the study team and the doctor who prescribed it before changing any medicine.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Autoimmune disease
A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.
Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants will wear an intra-oral appliance (IOA) containing enamel specimens and brush and rinse twice daily with a negative-control toothpaste and slurry that contains no active fluoride. This arm provides a baseline reference for evaluating enamel fluoride uptake and remineralization responses relative to the test and comparator treatments.
Drug: Negative Control Treatment Slurry (Fluoride-Free)
Participants will wear an intra-oral appliance (IOA) containing enamel specimens and brush and rinse twice daily with a commercially available fluoride toothpaste and slurry of known efficacy in promoting enamel fluoride uptake and surface remineralization. This arm serves as an established reference standard for evaluating the performance of the test formulation.
Drug: Active Comparator Fluoride Treatment (0.454% SnF)
Participants will wear an intra-oral appliance (IOA) containing enamel specimens and brush and rinse twice daily with the investigational fluoride toothpaste and slurry. This arm evaluates the ability of the test formulation to promote enamel fluoride uptake and remineralization relative to both the negative control and active comparator treatments.
Drug: Test Fluoride Treatment (0.454% SnF) (Investigational Toothpaste)
Fluoride-free toothpaste used with an intra-oral appliance (IOA) containing enamel specimens. Toothbrushing and rinsing with slurry twice daily for 2 minutes per administration while wearing the IOA, followed by expectoration without rinsing. Used to provide a baseline reference for enamel fluoride uptake and remineralization outcomes in an IOA model.
Commercially available stannous fluoride toothpaste Toothbrushing and rinsing with slurry twice daily for 2 minutes per administration while wearing the IOA containing enamel specimens, followed by expectoration without rinsing. Serves as an established reference for promoting enamel fluoride uptake and surface remineralization in an IOA model.
Investigational stannous fluoride toothpaste Toothbrushing and rinsing with slurry twice daily for 2 minutes per administration while wearing the IOA containing enamel specimens, followed by expectoration without rinsing. Intended to evaluate enamel fluoride uptake and remineralization performance versus negative control and active comparator treatments in an IOA model.
Percent Surface Microhardness Recovery (%SMHR)
Time frame: End of each 9-day test period (three test periods in total)
Post-treatment fluoride concentration (µg F/g enamel)
Time frame: End of each 9-day test period (three test periods in total)
Plan to share: No — The sponsor does not plan to share individual participant data (IPD) from this study. Summary results will be provided as required, but no de-identified datasets or additional supporting documents will be made available.
No publications or documents are linked to this record.
Ran from Aug 2024 to primary completion in Nov 2024, 3 months.
Of 33 industry-sponsored interventional studies with no phase under Dental Caries, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 24. This study's 3 months is below that.
Counting every sponsor, half of 502 studies reached it within 15 months; a quarter within 7 and three quarters within 29.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Church & Dwight Company, Inc. →